EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Circulating tumor cells in lobular versus ductal metastatic breast cancer

Emily M Dolce, Elizabeth P Darga, Nicholas C Henderson, Dafydd G Thomas, David A Hanauer, Arul M Chinnaiyan, Erin F Cobain, N Lynn Henry, Costanza Paoletti, Andi K Cani, Daniel F Hayes

Breast Cancer Research and Treatment · 2026

DOI: 10.1007/s10549-026-08111-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer Research and Treatment, 2026. Verfasst von Emily M Dolce und 10 weiteren Autor:innen. Beteiligte Einrichtung: Breast Oncology Section, Department of Internal Medicine, University of Michigan Medical School, CCC 6431, 1500 E. Medical Center Drive, MI, Ann Arbo…. Hauptthemen laut MEDLINE: Neoplastic Cells, Circulating, Breast Neoplasms, Carcinoma, Lobular, Carcinoma, Ductal, Breast. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Infiltrating lobular carcinoma (ILC) accounts for ~ 10% of all invasive breast cancer histologies. ILC is associated with worse prognosis than infiltrating ductal cancer. Circulating tumor cells (CTCs) are commonly elevated in metastatic breast cancer (mBC) and elevated levels of CTCs are associated with worse prognosis in breast cancers. We investigated CTC incidence in ILC in two patient cohorts.

Methods

Data from electronic medical records at the University of Michigan were identified using the EMERSE search engine to assess CTC levels in patients with mBC, using CellSearch ® . Findings were validated in a separate cohort of mBC patients who participated in a research protocol where CTC were analyzed.

Results

Within the EMERSE cohort of 218, 38 (17%), 29 (13%) and 151 (69%) patients, had lobular, mixed, and ductal mBC subtype, respectively. Overall, 101/218 (46%) patients had elevated CTC (≥ 5/7.5 ml whole blood). In this cohort, patients with ILC were more likely to have elevated CTCs (28/38; 74%) compared to those with mixed (14/29; 48%) or ductal (59/151; 39%) mBC ( p = 0.001). In multivariate regression, patients with ILC were seven times more likely than ductal mBC to have elevated CTCs. These data were validated in 146 separate mBC patients in the research cohort. Elevated CTCs were detected in 79%, 31%, and 36% of patients with lobular, mixed and ductal mBC, respectively.

Conclusion

CTC are more commonly elevated and tend to be higher in magnitude in patients with lobular compared to ductal mBC. CTC levels in mixed ductal-lobular morphology numerically more resemble ductal mBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplastic Cells, CirculatingBreast NeoplasmsCarcinoma, LobularCarcinoma, Ductal, BreastHumansFemaleMiddle AgedAgedPrognosisNeoplasm MetastasisAdultBiomarkers, Tumor

Stichwörter der Autor:innen

Breast cancerCirculating tumor cellsInvasive lobular breast carcinoma

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Breast Oncology Section, Department of Internal Medicine, University of Michigan Medical School, CCC 6431, 1500 E. Medical Center Drive, MI, Ann Arbor, 48109-5942, USA.
  • University of Michigan Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA.
  • Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
  • Department of Pathology and Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI, USA.
  • Department of Pediatrics and School of Information, University of Michigan, Ann Arbor, MI, USA.
  • Breast Oncology Section, Department of Internal Medicine, University of Michigan Medical School, CCC 6431, 1500 E. Medical Center Drive, MI, Ann Arbor, 48109-5942, USA. hayesdf@umich.edu.

Förderung

  • NCI NIH HHS
  • NIH HHS
  • National Institutes of Health
  • Dynami Foundation

Zitieren

APA

Dolce, E. M., Darga, E. P., Henderson, N. C., Thomas, D. G., Hanauer, D. A., Chinnaiyan, A. M., Cobain, E. F., Henry, N. L., Paoletti, C., Cani, A. K., & Hayes, D. F. (2026). Circulating tumor cells in lobular versus ductal metastatic breast cancer. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-026-08111-3

Vancouver

Dolce EM, Darga EP, Henderson NC, Thomas DG, Hanauer DA, Chinnaiyan AM, et al. Circulating tumor cells in lobular versus ductal metastatic breast cancer. Breast Cancer Research and Treatment. 2026. doi:10.1007/s10549-026-08111-3

BibTeX
@article{Dolce2026,
  author = {Dolce, Emily M and Darga, Elizabeth P and Henderson, Nicholas C and Thomas, Dafydd G and Hanauer, David A and Chinnaiyan, Arul M and Cobain, Erin F and Henry, N Lynn and Paoletti, Costanza and Cani, Andi K and Hayes, Daniel F},
  title = {Circulating tumor cells in lobular versus ductal metastatic breast cancer},
  journal = {Breast Cancer Research and Treatment},
  year = {2026},
  doi = {10.1007/s10549-026-08111-3}
}
Kostenlos starten →